NCIS Oncology Grand Rounds: Theranostics – Promises and Challenges in Early Phase Anti-Cancer Therapeutics Development
The session will cover real-world application of radioligands in these cancer types. Key topics include the therapeutic mechanisms of radioligands, the unique advantages of using these compounds for targeted treatment, and an overview of the early-stage clinical development. Additionally, the seminar will address the technical and regulatory challenges faced in developing anti-cancer radioligands, such as targeting specificity, safety, and cost-effectiveness.
Allied Health Professionals, General Practitioners, Nurses, Specialist Doctors, Other Healthcare Professionals
